Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(₁₄₅) or Lys(₁₄₆) from fPSA without internal cleavages at Lys(₁₄₅) or Lys(₁₄₆).
Total levels of circulating prostate-specific antigen (tPSA) are strongly associated with prostate cancer (PCa) risk and outcome but benign prostate disease is the most frequent cause of a moderately elevated PSA level. Free PSA (fPSA) forms are independently associated with PCa risk and contribute...
मुख्य लेखकों: | Peltola, M, Niemelä, P, Alanen, K, Nurmi, M, Lilja, H, Pettersson, K |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2011
|
समान संसाधन
-
Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
द्वारा: Nurmikko, P, और अन्य
प्रकाशित: (2002) -
Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
द्वारा: Nurmikko, P, और अन्य
प्रकाशित: (2000) -
Cleavage specificities of the brother and sister proteases Lys-C and Lys-N.
द्वारा: Raijmakers, R, और अन्य
प्रकाशित: (2010) -
Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.
द्वारा: Nurmikko, P, और अन्य
प्रकाशित: (2001) -
Lys chair.
द्वारा: Nur'Iffah Sa'adon.
प्रकाशित: (2010)